Sonoma Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Sonoma Pharmaceuticals, Inc. (SNOA) on July 15, 2021. The filing primarily addresses a change in the company's independent registered public accounting firm and provides context regarding prior financial statement restatements.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the current period. However, it references historical audit reports for the years ended March 31, 2021, and 2020, which contained explanatory paragraphs noting "substantial doubt" regarding the company's ability to continue as a going concern due to significant losses and the need to raise additional funds.
Material Changes and Events
- Change in Accountants: Effective July 15, 2021, the company dismissed Marcum, LLP as its independent registered public accounting firm following the completion of the audit for the year ended March 31, 2021.
- New Auditor: Frazier & Deeter, LLC was engaged as the independent registered public accounting firm for the fiscal year ending March 31, 2022, subject to audit committee approval.
- Prior Restatement: The filing discloses that the unaudited condensed consolidated interim financial statements for the quarter ended June 30, 2020, contained material errors. These statements were restated and filed on November 17, 2020.
- No Disagreements: The company reported no disagreements with Marcum, LLP regarding accounting principles, practices, or auditing scope during the most recent fiscal years.
Outlook, Risks, and Management Commentary
Management commentary is limited to the explanation of the auditor change and the historical context of the going concern doubt. The primary risk highlighted is the company's historical financial instability, characterized by significant losses and the necessity of raising capital to sustain operations. The filing confirms that the prior auditor's reports did not contain an adverse opinion or disclaimer, aside from the going concern explanatory paragraph.
Key Facts for Investor Verification
- Verify the status of the engagement with the new auditor, Frazier & Deeter, LLC, for the fiscal year ending March 31, 2022.
- Review the restated financial statements for the quarter ended June 30, 2020, to understand the nature of the material errors previously identified.
- Assess the company's current liquidity position and capital raising efforts given the historical "substantial doubt" regarding its ability to continue as a going concern.
- Confirm the content of the consent letter from Marcum, LLP (Exhibit 16.1) to ensure no undisclosed disagreements exist.